Ropivacaine: An update of its use in regional anaesthesia

Drugs

Volumn 60, Issue 5, 2000, Pages 1065-1093

  McClellan, Karen J ^a   Faulds, Diana ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; FENTANYL; FLUVOXAMINE; KETOCONAZOLE; LIDOCAINE; MEPIVACAINE; MORPHINE; OPIATE; ROPIVACAINE; SUFENTANIL;

CARDIOTOXICITY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; HUMAN; NEUROTOXICITY; NONHUMAN; PAIN; PRACTICE GUIDELINE; REGIONAL ANESTHESIA; REVIEW;

EID: 84869883428     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200060050-00007     Document Type: Review

References (161)

1. Drugs in anaesthetic practice and analgesia
2. Recent advances: Anaesthesia
3. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine
4. Reduced cardiotoxicity of levobupivacaine compared with racemic bupivacaine (Marcaine): New clinical evidence
5. Ropivacaine: A review of its pharmacology and therapeutic use in regional anaesthesia
6. Molecular mechanisms of local anesthesia: A review
7. Fundamental properties of local anesthetics. II. Measured octanol: Buffer partition coefficients and pK(a) values of clinically used drugs
8. Differential sensitivity of A and C nerve fibres to long-acting amide local anaesthetics
9. Comparison of bupivacaine- and ropivacaine-induced conduction blockade in the isolated rabbit vagus nerve
10. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: A double-blind study
11. Actions of three local anaesthetics: Lidocaine, bupivacaine and ropivacaine on guinea pig papillary muscle sodium channels (V(max))
12. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics
13. Mitochondrial effects of l-ropivacaine, a new local anesthetic
14. Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle
15. Cardiac electrophysiologic properties of bupivacaine and lidocaine compared with those of ropivacaine, a new amide local anesthetic
16. The effects of bupivacaine and ropivacaine on cardiomyocyte contractility and excitability in rats
17. Cardiotoxicity of ropivacaine-a new amide local anaesthetic agent
18. Systolic functional effects of racemic bupivacaine (B), levobupivacaine (L) and ropivacaine (R): An experimental study in anaesthetized swine
19. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
20. Acute toxicity of ropivacaine compared with that of bupivacaine
21. Skin blood flow after intradermal injection of ropivacaine in various concentrations with and without epinephrine evaluated by laser Doppler flowmetry
22. The effects of epidural ropivacaine and bupivacaine for cesarean section on uteroplacental and fetal circulation
23. Peripheral nervous system. The human nervous system. 4th ed.
24. Structure-activity relationships in differential nerve block at high and low frequency stimulation
25. Local anesthetic toxicity: An update
26. Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block
27. Mechanism for bupivacaine depression of cardiac conduction: Fast block of sodium channels during the action potential with a slow recovery from block during diastole
28. Comparative toxicity of ropivacaine and bupivacaine at equipotent dose in rats
29. Cardiotoxic effects of levobupivacaine, bupivacaine and ropivacaine - An experimental study in pentobarbital anesthetized swine
30. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog
31. Effect of ropivacaine and bupivacaine on uterine blood flow in pregnant ewes
32. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: Implications for therapeutic indexes
33. Relative potencies of bupivacaine and ropivacaine for analgesia in labour
34. 0.125% Ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion
35. Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery
36. Double-blind comparison of epidural ropivacaine 0.25% and bupivacaine 0.25%, for the relief of childbirth pain
37. Comparison of ropivacaine and bupivacaine in extradural analgesia for the relief of pain in labour
38. A double-blind comparison of 0.25% ropivacaine and 0.25% bupivacaine for extradural analgesia in labour
39. Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labor: A double-blind comparison
40. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: A prospective meta-analysis
41. A double-blind, randomized, parallel investigation into neurobehavioural status and outcome of infants born to mothers receiving epidural ropivacaine 0.25% and bupivacaine 0.25% for analgesia in labour
42. Ropivacaine and bupivacaine for analgesia in labour
43. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for Caesarean section
44. Epidural ropivacaine 7.5 mg/ml for elective Caesarean section: A double-blind comparison of efficacy and tolerability with bupivacaine 5 mg/ml
45. Feto-maternal distribution of ropivacaine and bupivacaine after epidural administration for cesarean section
46. Ropivacaine 0.75% for extradural anaesthesia in elective Caesarean section: An open clinical and pharmacokinetic study in mother and neonate
47. Ropivacaine 7.5 mg/ml for elective Caesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg
48. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers
49. Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block
50. Ropivacaine 0.25% and 0.5%, but not 0.125% provide effective wound infiltration analgesia after outpatient hernia repair, but with sustained plasma drug levels
51. Wound infiltration and drain lavage with ropivacaine after major shoulder surgery
52. Clinical efficacy and pharmacokinetics of 1% ropivacaine and 0.75% bupivacaine in peribulbar anaesthesia for cataract surgery
53. Comparison of the uptake of ropivacaine and bupivacaine from the knee joint
54. Pharmacokinetics and clinical effect during continuous epidural infusion with ropivacaine 2.5 mg/ml or bupivacaine 2.5 mg/ml for labour pain relief
55. Disposition kinetics of ropivacaine in humans
56. Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers
57. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief
58. Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia
59. Epidural infusion of ropivicaine for postoperative analgsia after major orthopedic surgery: Pharmacokinetic evaluation
60. Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects
61. Metabolism and excretion of ropivacaine in humans
62. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes
63. Pharmacokinetics and clinical efficacy of long-term epidural ropivicaine infusion in children
64. Pharmacokinetics of lumbar epidural ropivacaine in children and adolescents
65. The dose-response of caudal ropivacaine in children
66. Pharmacokinetics of ropivacaine following caudal analgesia in children
67. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors
68. Epidural ropivacaine for the initiation of labor epidural analgesia: A dose finding study
69. -1 for pain relief during labour
70. Comparative evaluation of four different infusion rates of ropivacaine (2 mg/mL) for epidural labor analgesia
71. Epidural 0.2% ropivacaine for labour analgesia: Parturient-controlled or continuous infusion?
72. Ropivacaine, 0.1%, plus sufentanil, 0.5 μg/ml, versus bupivacaine, 0.1%, plus sufentanil, 0.5 μg/ml, using patient-controlled epidural analgesia for labor
73. A double-blind comparison of 0.125% ropivacaine with sufentanil and 0.125% bupivacaine with sufentanil for epidural labor analgesia
74. A comparison of epidural analgesia with 0.125% ropivacaine with fentanyl versus 0.125% bupivacaine with fentanyl during labor
75. Ambulatory labor epidural analgesia: Bupivacaine versus ropivacaine
76. A comparison between low-dose ropivacaine and bupivacaine at equianalgesic concentrations for epidural analgesia during the first stage of labor
77. Low dose intrathecal ropivacaine and sufentanil is safe in labor and does not impair motor strength
78. Intrathecal ropivacaine 1.25 mg vs. 2.5 mg for labor analgesia - Comparison of maternal and fetal complications
79. Determination of dose response for intrathecal ropivacaine in laboring parturients
80. Efficacy analysis between ropivacaine and bupivacaine for combined-spinal epidural labor analgesia
81. Intrathecal ropivacaine for labor analgesia: A comparison with bupivacaine
82. Postoperative analgesia with no motor block by continuous epidural infusion of ropivacaine 0.1% and sufentanil after total hip replacement
83. Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery: A dose-finding study
84. Postoperative analgesia by continuous extradural infusion of ropivacaine after upper abdominal surgery
85. Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery: A dose-finding study
86. Epidural ropivacaine infusion for postoperative analgesia after major lower abdominal surgery - A dose finding study
87. Continuous epidural ropivacaine 0.2% for analgesia after lower abdominal surgery
88. Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery
89. Comparison between extradural infusion of ropivacaine or bupivacaine for the prevention of postoperative pain after total knee arthroplasty
90. Continuous epidural infusion of ropivacaine for postoperative analgesia after major abdominal surgery: Comparative study with i.v. PCA morphine
91. Ropivacaine epidural anesthesia and analgesia versus general anesthesia and intravenous patient-controlled analgesia with morphine in the perioperative management of hip replacement
92. A comparison of epidural ropivacaine infusion alone and in combination with 1,2 and 4 μg/mL fentanyl for seventy-two hours of postoperative analgesia after major abdominal surgery
93. Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl
94. Epidural analgesia with local anesthetics after abdominal surgery: Earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine
95. What concentration of sufentanil should be combined with ropivacaine 0.2% wt/vol for postoperative patient-controlled epidural analgesia?
96. Preoperative local infiltration with ropivacaine for postoperative pain relief after inguinal hernia repair: A randomised controlled trial
97. Pain relief by wound infiltration with bupivacaine or high-dose ropivacaine after inguinal hernia repair
98. High-dose ropivacaine wound infiltration for pain relief after inguinal hernia repair: A clinical and pharmacokinetic evaluation
99. Preoperative infiltration with novocaine 10% to improve postoperative pain control in thoracic surgery
100. Pre-emptive analgesia with ropivacaine during breast reconstruction
101. Local anaesthetic infiltration for postoperative wound pain in lumbar laminectomy. Comparative study with bupivacaine and ropivacine
102. Postoperative pain control in vertebral stabilization surgeries our experience
103. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route
104. Ropivacaine in paediatric surgery: Preliminary results
105. Comparison of ropivacaine with bupivacaine for paediatric caudal block
106. Caudal block in children: Ropivacaine compared with bupivacaine
107. Ropivacaine vs bupivacaine in major surgery in infants
108. Ropivacaine vs. ropivacaine-clonidine for caudals in children
109. Ropivacaine-clonidine combination for caudal blockade in children
110. A comparison between ropivacaine and ropivacaine-clonidine for continuous epidural postoperative analgesia in children
111. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section
112. Extradural anaesthesia for Caesarean section a double-blind comparison of 05% ropivacaine with 05% bupivacaine
113. Epidural anesthesia for cesarean section: A double-blind comparison between 7.5 mg/ml ropivacaine and 5 mg/ml bupivacaine
114. Epidural anaesthesia for caesarean section: Double-blind comparison of ropivacaine, 7.5 mg/ml, and bupivacaine, 5 mg/ml
115. Ropivacaine 7.5 mg/ml for epidural anesthesia in elective cesarean section: A comparison with 5 mg/ml bupivacaine
116. A double-blind comparison of 0.5% bupivacaine and 0.75% ropivacaine administered epidurally in humans
117. Ropivacaine 1% versus bupivacaine 0.75% without a vasoconstrictor. A comparative study of epidural anesthesia in orthopedic surgery
118. The equipotency of ropivacaine, bupivacaine and etidocaine
119. Comparison of 0.5% ropivacaine and 0.5% bupivacaine for epidural anesthesia in patients undergoing lower-extremity surgery
120. Comparison of 0.5% ropivacaine and 0.5% bupivacaine in lumbar epidural anaesthesia for lower limb orthopaedic surgery
121. An open study of ropivacaine in extradural anaesthesia
122. An open study comparison of 0.5%, 0.75% and 1.0% ropivacaine, with epinephrine, in epidural anesthesia in patients undergoing urologic surgery
123. Comparison of 0.75% ropivacaine with epinephrine and 0.75% bupivacaine with epinephrine in lumbar epidural anesthesia
124. A comparison of epidural 1% ropivacaine and 0.75% bupivacaine for lower abdominal gynecologic surgery
125. A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy
126. Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine
127. An exploratory study of 0.5% ropivacaine with epinephrine and 0.5% ropivacaine without epinephrine when used for brachial plexus anesthesia in patients undergoing surgery of the upper limb
128. Efficacy of a new local anaesthetic - 0.5% ropivacaine - For brachial plexus block
129. A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block
130. Patient-controlled interscalene analgesia with ropivacaine after major shoulder surgery: PCIA vs PCA
131. Patient-controlled interscalene analgesia with ropivacaine 0.2% versus patient-controlled intravenous analgesia after major shoulder surgery
132. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for bracheal plexus block
133. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: A clinical comparison with 0.5% bupivacaine
134. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia
135. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block
136. -1 for supra clavicular brachial plexus anesthesia
137. A double-blind study of axillary brachial plexus block by 0.75% ropivacaine or 2% mepivacaine
138. Interscalene brachial plexus anaesthesia with 0.5%, 0.75% or 1% ropivacaine: A double-blind comparison with 2% mepivacaine
139. A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade
140. Ropivacaine or 2% mepivacaine for lower limb peripheral nerve blocks
141. Lumbar plexus and sciatic nerve block for knee arthroplasty: Comparison of ropivacaine and bupivacaine
142. Three-in-one blocks with ropivacaine: Evaluation of sensory onset time and quality of sensory block
143. Intrathecal ropivacaine for ambulatory surgery: A comparison between intrathecal bupivacaine and intrathecal ropivacaine for knee arthroscopy
144. Cervical plexus anesthesia for carotid endarterectomy: Comparison of ropivacaine and mepivacaine
145. Comparison of 1% ropivacaine and mixture of 2% lignocaine and 0.5% bupivacaine for peribulbar anaesthesia in cataract surgery
146. Lidocaine plus ropivacaine versus lidocaine plus bupivacaine for peribulbar anesthesia by single medial injection
147. Ropivacaine for peribulbar anesthesia
148. A comparison of 1% ropivacaine with a mixture of 0.75% bupivacaine and 2% lignocaine for peribulbar anaesthesia
149. Ropivacaine in peribulbar block: A comparative study with bupivacaine
150. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients
151. Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: A double-blinded study
152. Accidental i.v. injections of ropivacaine: Clinical experiences of six cases
153. Convulsions induced by ropivacaine during interscalene brachial plexus block
154. Ropivacaine-induced convulsions and severe cardiac dysrhythmia after sciatic block
155. Ropivacaine-induced seizure after extradural anaesthesia
156. Anxiety, vocalization, and agitation following peripheral nerve block with ropivacaine
157. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride
158. Strategies for labor pain relief - Past, present and future
159. Comparative effect of racemic bupivacaine, levobupivacaine and ropivacaine on isolated rabbit heart
160. Levobupivacaine: A review of its pharmacology and use as a local anaesthetic